The ECCO 2019 European Cancer Summit took place on 12-14 September 2019 in Brussels, Belgium, providing a focal point for resolution on the burning matters affecting access to high quality cancer care for patients across Europe. The Summit brought together around 350 delegates from cancer care, research, patient advocacy and public-private sectors in a unique multi-stakeholder forum.

The second day of the ECCO Cancer Summit 2019 closed with a very intense session “How does access to innovative cancer medicines fit in high quality cancer care and well-functioning health system as a whole?”, moderated by Teodora Kolarova, Executive Director of International Neuroendocrine Cancer Alliance (INCA) and member of ECCO Patient Advisory Committee, and Maria Krini, Member of ECL Access to Medicines Task Force, Dr Kim Linton, Clinical Senior Lecturer in the Division of Molecular & Clinical Cancer Sciences at The University of Manchester, Dr Detlev Parow, Head of Patient Care Management at DAK-Gesundheit, Germany, Usman Khan, Executive Director of the European Patients’ Forum and Alexandre Lourenço, President of the Portuguese Association of Hospital Managers, discussed the instrumental significance of patient participation in the decision process, the concept of risk sharing, the need to redesign the healthcare system model and the responsibility of all stakeholders in facilitating access to optimal treatment and care.

For more information about the forum, please visit ECCO 2019 European Cancer Summit